Question 1

What is Avalyn Pharma?

Accepted Answer

Avalyn Pharma is a Entity.

Question 2

How often does Avalyn Pharma appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Avalyn Pharma first tracked by Ergen?

Accepted Answer

First tracked on May 21, 2026.

Question 4

When was Avalyn Pharma last mentioned in news?

Accepted Answer

Last active on May 21, 2026.

Question 5

What is Avalyn Pharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Avalyn Pharma in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Avalyn Pharma?

Accepted Answer

Avalyn Pharma presents AP01 data (May 21, 2026, 6 articles).

Question 8

How did the "Avalyn Pharma presents AP01 data" event impact Avalyn Pharma?

Accepted Answer

Avalyn Pharma is presenting positive long-term data for its AP01 inhaled pirfenidone, which could enhance its market position in treating pulmonary fibrosis and other respiratory diseases. This event highlights the company's progress in developing optimized inhaled therapies.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.